AwardedEuropean

Voluntary transparency radiopharmaceuticals

Name: Voluntary transparency radiopharmaceuticals
Creator: Radboud Universitair Medisch Centrum/Radboudumc
Published: 2026-01-15
License: https://creativecommons.org/publicdomain/zero/1.0/
Keywords: radiopharmaceuticals, radioactive substances, medical, pharmaceuticals, GE Healthcare

Radboud Universitair Medisch Centrum/Radboudumc · 1 lots · 408130

0 of 6 core insights found

Measures presence, not accuracy · documents remain authoritative

ScopeAdvicePoints of attentionSuitability requirementsAward criteriaTimeline

Type

—

09343000

Estimated value

Not published

To deadline

Ongoing

Knock-outs

n/a

exclusion grounds

Award basis

Best price-quality ratio

Assess manuallyconfidence low

Radboudumc has purchased radiopharmaceuticals from GE Healthcare via a negotiated procedure without prior call for competition. The contract concerns radioactive substances (CPV [telefoonnummer verwijderd]) and has been awarded for a symbolic €1. This is of interest to specialized pharmaceutical companies with expertise in radioactive medicines.

Contract · European procedure

European

Contracting authority

Radboud Universitair Medisch Centrum/Radboudumc

Contract type

Not specified

Estimated value

Estimate not published

Submission deadline

Ongoing

Scope

European

European procedure

Lots

1 lots

Main CPV code

09343000

Location

Netherlands

CharacteristicsCPV 09EU tenderradiopharmaceuticalsradioactive substancesmedical

01What is being requested

Radboudumc has purchased radiopharmaceuticals from GE Healthcare via a negotiated procedure without prior call for competition. The contract concerns radioactive substances (CPV [telefoonnummer verwijderd]) and has been awarded for a symbolic €1. This is of interest to specialized pharmaceutical companies with expertise in radioactive medicines.

Voluntary transparency concerns the supply of radiopharmaceuticals.

09343000

1Voluntary transparency radiopharmaceuticals—

02Outcome

Awarded

GE Healthcare Pharmaceutical Diagnostics

03Exclusion grounds

Exclusion grounds — consult the ESPD

No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Bidders in this segment

#Likely bidderFitWins

1GE Healthcare Pharmaceutical DiagnosticsUnknown701×

2Cis Bio InternationalUnknown661×

3Eneco Zakelijk B.V.SME4821×

4De Groene Stroomfabriek N.V.SME4819×

5VanHelderUnknown4513×

6Multi Tank Card B.V.SME4416×

05Legal themes that may be relevant here

Advies 59> Meervoudig onderhandse aanbestedingsprocedure met betrekking tot een opdracht voor de levering van postdiensten en bezorging. In Advies 222> Aanbesteding via een marktplaats. De Commissie bevestigt haar eerdere adviezen (waaronder 147) dat op een aanbestedende dienst d Advies 243> Meervoudig onderhandse procedure. Dat de aanbestedende dienst met een SaaS (Software as a Service) oplossing besparingen zou kun Advies 81> Europese openbare aanbestedingsprocedure voor het leveren en exploiteren van wachthuisjes en informatiepanelen. Eisen en criteri Advies 121> Nationale openbare aanbestedingsprocedure. Kan van inschrijvers gevraagd worden een opgave te doen van onvoorziene gebeurtenisse

06Frequently asked questions

Which selection requirements must a bidder meet?

Bidders must have experience with radioactive substances and relevant certifications for radiopharmaceuticals.

Which suitability criteria apply?

For this contract, expertise in radiopharmaceutical products and certification for radioactive materials is required.

Automatically compiled from the official tender data and documents.

07Estimated value versus the market

p25
€ 300K

median
€ 700K

p75
€ 2,2 mln

deze opdracht

Gegunde waarden in CPV 09 n=227